Blood Transfusions — NCD 154 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 154 governing Medicare blood transfusion coverage policy, effective March 7, 2026. Here's what billing teams need to know before claims start hitting the wrong denial bucket.

CMS updated National Coverage Determination 154, which governs Medicare coverage of blood transfusions — including homologous, autologous, donor-directed, and perioperative blood salvage procedures — under both Part A and Part B. The modification clarifies coverage rules across inpatient and outpatient settings and draws a firm line between covered transfusion services and non-covered preoperative blood donation services. This policy does not list specific CPT or HCPCS codes, but the rules it establishes have direct consequences for how hospitals, outpatient facilities, and non-hospital Part B suppliers bill for transfusion-related services.

Quick-Reference Table

CMS Blood Transfusion Coverage Criteria and Medical Necessity Requirements 2026

The core medical necessity standard for Medicare blood transfusion coverage under NCD 154 is straightforward: a medically necessary transfusion of blood is a covered service under both Part A and Part B. That coverage applies regardless of whether the blood is homologous (collected from the general public), autologous (the patient's own pre-collected blood), or donor-directed (pre-collected from a designated individual for a specific patient).

CMS does not distinguish between those three transfusion types for coverage purposes. If the transfusion is medically necessary, it's covered. The clinical indications explicitly recognized by the policy are restoring blood volume after hemorrhage, improving oxygen-carrying capacity in severe anemia, and combating shock in acute hemolytic anemia.

Where this gets complicated — and where your billing team needs to pay close attention — is the sharp distinction CMS draws between the transfusion itself and the preoperative services that precede it. Collection, processing, and storage of autologous or donor-directed blood before a procedure are treated very differently depending on the billing context.

Hospital Inpatient and Outpatient (Part A and B)

Under the prospective payment system (PPS), the DRG payment covers all blood and blood processing expenses, whether or not the blood is eventually used. That last clause matters. If a patient pre-deposits autologous blood for surgery and the surgery gets cancelled, the DRG payment still covers the collection and processing costs — the hospital doesn't get a separate line-item reimbursement.

Hospitals that operate their own blood collection activities record those costs in the whole blood and packed red blood cells cost center. Medicare does not recognize a separate charge for the blood itself when the blood supply has been replaced. The DRG is the payment mechanism, full stop.

Non-Hospital Part B Suppliers

This is where NCD 154 draws its hardest line, and it's the area most likely to generate claim denials if your billing team isn't aligned on the rules.

Under Part B, services eligible for separate coverage must fit one of the defined service categories under §1832 of the Act, as codified in 42 CFR 410.10. Blood donation services — collection, processing, and storage of autologous or donor-directed blood for later transfusion — do not qualify as a separately covered service category under Part B. There is no billing pathway through which a non-hospital blood supplier can receive direct Part B payment for those services.

If your organization is a free-standing blood bank or independent supplier billing Medicare directly for autologous or donor-directed blood donation services, those claims will be denied. That's not ambiguous — NCD 154 closes that door explicitly.

CMS Blood Transfusion Exclusions and Non-Covered Indications

The policy is explicit about what Medicare will not cover as a separately billable service: preoperative collection, processing, and storage of autologous or donor-directed blood billed by a non-hospital Part B supplier.

This exclusion exists because there's no defined service category under Part B statutes that accommodates these services. It's not a medical necessity question — it's a structural benefit category question. The blood could be clinically appropriate and still be non-covered for billing purposes because the service doesn't fit the Part B framework.

Perioperative blood salvage — collection and reinfusion of blood lost during or immediately after surgery — is addressed separately in the policy under Section C. The full text of that section was truncated in the available policy data. If your facility or surgical program uses intraoperative cell salvage, review the complete NCD 154 text and talk to your compliance officer about how the perioperative salvage rules apply to your specific billing scenarios before March 7, 2026.

Coverage Indications at a Glance

CMS Blood Transfusion Billing Guidelines and Action Items 2026

CPT, HCPCS, and ICD-10 Codes for Blood Transfusions Under NCD 154

NCD 154, as updated effective March 7, 2026, does not list specific CPT, HCPCS Level II, or ICD-10-CM codes within the policy document. This is unusual compared to more code-specific NCDs, and it's worth flagging — it means the coverage rules apply broadly across transfusion billing without being anchored to a defined code set within the NCD itself.

For billing purposes, you'll need to cross-reference your transfusion CPT codes (including administration codes and blood product codes) against this policy's coverage criteria and your local Medicare Administrative Contractor (MAC) guidance. Your MAC may have Local Coverage Determinations (LCDs) or billing articles that specify which codes apply to these services in your jurisdiction.

If you're uncertain which codes your MAC expects for transfusion billing under NCD 154, contact your MAC's provider outreach team or work with your billing consultant to map your charge master to the policy's criteria. Don't wait on that — March 7, 2026 is the effective date, and MACs won't always send proactive notices when an NCD update changes how they adjudicate claims.